Summary by Moomoo AI
Clene Inc. has updated its prospectus supplement on May 8, 2024, to adjust the maximum aggregate gross sales price of its common stock offering to $12,300,000. This amendment is filed with the SEC and modifies the previous prospectus supplement dated November 7, 2023, and the accompanying prospectus dated April 26, 2022. The sales of the common stock will be conducted through Canaccord Genuity LLC, acting as the sales agent, on an 'at the market offering' basis as defined by Rule 415(a)(4). Canaccord Genuity is entitled to a commission of up to 3.0% per share sold and will also receive indemnification against certain liabilities. Clene's common stock and public warrants are traded on the Nasdaq under the symbols 'CLNN' and 'CLNNW,' with the last reported sale prices on...Show More